Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02603757 · ClinicalTrials.gov registry record · NA
Effectiveness of High Dose Vitamin D Supplementation in Stage III Colorectal Cancer
A NA study, sponsored by Legacy Health System.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT02603757 is a NA study that has completed, run by Legacy Health System. The registered enrollment target is 70 participants.
The verdict
NCT02603757, a NA study, has completed, sponsored by Legacy Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
This is a pilot study to test whether there is an association between baseline Vitamin D levels, Vitamin D supplementation and survival in patients with stage III colon and stage II/III rectal cancer receiving chemotherapy. 70 patients with colon stage III or rectal stage II or III cancer that require chemotherapy will be screened and 60 patients will be enrolled. Patients will be randomized to standard dose (2000 IU daily) or high-dose (50,000 IU weekly) Vitamin D supplementation for 1 year after initiation of chemotherapy. Patients' Vitamin D levels will be checked throughout supplementation then followed for 5 years with occasional Vitamin D testing and surveying in order to collect information on recurrence and survival outcomes.
Interventions
- DIETARY_SUPPLEMENT cholecalciferol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2016-03 |
| Est. Completion | 2020-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02603757
The ClinicalTrials.gov registry entry for NCT02603757 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Legacy Health System, which has 21 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which cholecalciferol is the first listed.
NCT02603757 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02603757 about?
NCT02603757 is a clinical study titled "Effectiveness of High Dose Vitamin D Supplementation in Stage III Colorectal Cancer". This is a pilot study to test whether there is an association between baseline Vitamin D levels, Vitamin D supplementation and survival in patients with stage III colon and stage II/III rectal cancer receiving chemotherapy. 70 patients with colon stage III or rectal stage II or III cancer that requi...
What is the current status of trial NCT02603757?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2016-03. Estimated completion is 2020-06.
What interventions are being tested in trial NCT02603757?
The interventions under investigation include: cholecalciferol (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02603757?
This trial is sponsored by Legacy Health System, which has 21 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.